Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

November 16, 2021; 97 (20) Resident & Fellow section

Teaching Video NeuroImage: Clues in Myoclonus Evaluation

When to Consider Sialidosis

View ORCID ProfileBeatriz Vélez Gómez, Silvia Jesús, Daniel Macias-Garcia, Beatriz Lechon, View ORCID ProfilePablo Mir
First published July 14, 2021, DOI: https://doi.org/10.1212/WNL.0000000000012464
Beatriz Vélez Gómez
From the Unidad de Trastornos del Movimiento (B.V.G., S.J., D.M.-G., P.M., B.L.), Servicio de Neurología y Neurofisiología Clínica, Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla/ CSIC/Universidad de Sevilla; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (S.J., D.M.-G., P.M.), Madrid; and Servicio de Oftalmología (B.L.), Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Beatriz Vélez Gómez
Silvia Jesús
From the Unidad de Trastornos del Movimiento (B.V.G., S.J., D.M.-G., P.M., B.L.), Servicio de Neurología y Neurofisiología Clínica, Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla/ CSIC/Universidad de Sevilla; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (S.J., D.M.-G., P.M.), Madrid; and Servicio de Oftalmología (B.L.), Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Macias-Garcia
From the Unidad de Trastornos del Movimiento (B.V.G., S.J., D.M.-G., P.M., B.L.), Servicio de Neurología y Neurofisiología Clínica, Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla/ CSIC/Universidad de Sevilla; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (S.J., D.M.-G., P.M.), Madrid; and Servicio de Oftalmología (B.L.), Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatriz Lechon
From the Unidad de Trastornos del Movimiento (B.V.G., S.J., D.M.-G., P.M., B.L.), Servicio de Neurología y Neurofisiología Clínica, Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla/ CSIC/Universidad de Sevilla; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (S.J., D.M.-G., P.M.), Madrid; and Servicio de Oftalmología (B.L.), Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Mir
From the Unidad de Trastornos del Movimiento (B.V.G., S.J., D.M.-G., P.M., B.L.), Servicio de Neurología y Neurofisiología Clínica, Hospital Universitario Virgen del Rocío/Instituto de Biomedicina de Sevilla/ CSIC/Universidad de Sevilla; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (S.J., D.M.-G., P.M.), Madrid; and Servicio de Oftalmología (B.L.), Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pablo Mir
Full PDF
Citation
Teaching Video NeuroImage: Clues in Myoclonus Evaluation
When to Consider Sialidosis
Beatriz Vélez Gómez, Silvia Jesús, Daniel Macias-Garcia, Beatriz Lechon, Pablo Mir
Neurology Nov 2021, 97 (20) e2052-e2053; DOI: 10.1212/WNL.0000000000012464

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
487

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

A 53-year-old woman was presented for the evaluation of visual disturbances, generalized and multifocal myoclonus, and progressive ataxia that began at age 30 years (cf. Video 1). Bilateral cherry-red spots in the macula (figure) and a cortical origin in the EEG-EMG coregistration with back-averaging were observed. Reduced neuraminidase activity in fibroblasts and the homozygous mutation c.403G>A in the NEU1 gene confirmed the diagnosis of sialidosis type I.

Video 1

Cortical Myoclonus. We observed generalized and multifocal myoclonus at rest (segment 1). It worsens during a sustained posture, such as holding arms or legs out against gravity. The myoclonus activity also increases with tactile sensory stimulation (segment 2). It worsens with activities such as finger-nose-finger test (segment 3). The patient shows dysarthria. The speech facility deteriorates with myoclonus (segment 4).Download Supplementary Video 1 via http://dx.doi.org/10.1212/012464_Video_1

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Ophthalmic Examination: Cherry-Red Spot

The dilated fundus examination showed bilateral cherry-red spots on the retina. This is a red zone at the center of the macula surrounded by retinal opacification. It is due to the accumulation of different lipids, sphingolipid, or oligosaccharide material in the ganglion cells of the retina.

Sialidosis or cherry-red spot–myoclonus syndrome is classified into normomorphic or type I, beginning usually after 20 years old, whereas dysmorphic or type II begins at birth or in early childhood. In both, generalized myoclonus and ataxia can be found. EEG-EMG coregistration may show cortical potential followed by the myoclonus, proving a cortical origin. Differential diagnosis is necessary for other inherited metabolic disorders such as Tay-Sachs disease or Unverricht-Lundborg disease. Cherry-red spots on the retina, cortical myoclonus, and progressive ataxia are essential keys to suspicion.1,2

Study Funding

This research was supported by grants from the Spanish Ministry of Science and Innovation [RTC2019-007150-1], the Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (ISCIII-FEDER) [PI14/01823, PI16/01575, PI18/01898, and PI19/01576], the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía [CVI-02526 and CTS-7685], the Consejería de Salud y Bienestar Social de la Junta de Andalucía [PI-0471-2013, PE-0210-2018, PI-0459-2018, and PE-0186-2019], and the Fundación Alicia Koplowitz. Silvia Jesús has a “Acción B Clínicos-Investigadores” (Action B Clinicians-Researchers) contract [B-0007-2019] funded by the “Consejería de Salud y Familiar,” and Daniel Macías-García has a Río Hortega contract [CM18/00142] funded by the Health Institute Carlos III.

Disclosure

B. Vélez Gómez has received honoraria from Sanofi; S. Jesús has received honoraria from AbbVie, Bial, Merz, UCB, Italfarmaco, and Zambon; D. Macías-García has received honoraria from AbbVie, Teva, and Zambon; B. Lechon reports no disclosures relevant to the manuscript; and P. Mir has served in the advisory boards or received honorarium for lecturing from Abbott, Allergan, AbbVie, Bial, Britannia, Italfarmaco, Merz, UCB, Teva, and Zambon. Go to Neurology.org/N for full disclosures.

Appendix Authors

Table

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Teaching slides links.lww.com/WNL/B466

  • © 2021 American Academy of Neurology

References

  1. 1.↵
    1. Caciotti A,
    2. Melani F,
    3. Tonin R, et al.
    Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: an overview. Mol Genet Metab. 2020;129(2):47-58.
    OpenUrl
  2. 2.↵
    1. Orsini A,
    2. Valetto A,
    3. Bertini V, et al.
    The best evidence for progressive myoclonic epilepsy: a pathway to precision therapy. Seizure. 2019;71:247-257.
    OpenUrlCrossRef

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Study Funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • Resident & Fellow Rounds: November 2021

Topics Discussed

  • Epilepsy semiology
  • Retina
  • Myoclonus
  • Peroxisomes

Alert Me

  • Alert me when eletters are published
Neurology: 98 (21)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise